All About Lecanumab - A New FDA Approved Approach to Alzheimer’s Treatment

In response to interest from facility partners, our team put together a guide to facilitate answering questions that may arise from staff, residents, or their loved ones regarding the new Alzheimer’s treatment medication approved by the FDA, called Lecanumab (sold under the brand name Leqembi).

To learn more, click HERE for a 1-page guide with the top questions about this novel treatment.